S1‐Leitlinie Infizierte Zehenzwischenraum‐Intertrigo (sogenannter „gramnegativer Fußinfekt“)
Zusammenfassung Die infizierte Zehenzwischenraum‐Intertrigo bezeichnet eine exsudative, mazerierende oberflächliche Mischinfektion der Zehenzwischenräume, bei der gramnegative Bakterien (vor allem Pseudomonas aeruginosa, Enterobacterales) hervorstechen, aber regelmäßig auch grampositive Erreger (Staphylococcus [S.] aureus, koagulasenegative ...
Christoph Zeyen +10 more
wiley +1 more source
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection. [PDF]
Morita J +7 more
europepmc +1 more source
S1 Guideline on Infected Interdigital Intertrigo (also called Gram‐Negative Toe Web Infection)
Summary Infected interdigital intertrigo is an exudative, macerating, mixed infection of the toe webs in which gram‐negative bacteria (Pseudomonas aeruginosa and Enterobacterales) seem prevalent, but in which gram‐positive pathogens (Staphylococcus [S.] aureus, streptococci, enterococci) and fungi (dermatophytes, yeasts) also occur.
Christoph Zeyen +10 more
wiley +1 more source
Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults. [PDF]
Morita J +7 more
europepmc +1 more source
A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel β-lactamase inhibitor nacubactam. [PDF]
Morita J +7 more
europepmc +1 more source
Includes abstract. Includes bibliographical references (leaves 115-141)
Jongwe, Tsungai Ivai
core
Emergence of KPC-producing <i>Pseudomonas aeruginosa</i> in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam. [PDF]
Pérez-Rodríguez G +13 more
europepmc +1 more source
Evaluation of Phenotypic and Genotypic Susceptibility Testing Methods for Newer β-lactam/β-lactamase Inhibitor Combinations in Multidrug Resistant Pseudomonas aeruginosa. [PDF]
Hall CW +8 more
europepmc +1 more source

